tiprankstipranks
Encompass Health (MX:EHC)
NYSE:EHC
Mexico Market
EHC
Encompass Health
RESEARCH TOOLSreports

Encompass Health (EHC) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

EHC Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Encompass
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EHC Stock 12 Month Forecast

Average Price Target

$2,385.58
Based on 7 Wall Street analysts offering 12 month price targets for Encompass Health in the last 3 months. The average price target is $2,385.58 with a high forecast of $2,451.24 and a low forecast of $2,188.61. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1374":"$1,374","1913":"$1,913","2452":"$2,452","1643.5":"$1,643.5","2182.5":"$2,182.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2451.2378758,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.45K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2385.5797184125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.39K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2188.60524625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.19K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1374,1643.5,1913,2182.5,2452],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1875.83,1920.0921442923077,1964.3542885846152,2008.616432876923,2052.8785771692305,2097.1407214615383,2141.402865753846,2185.665010046154,2229.9271543384616,2274.1892986307694,2318.4514429230767,2362.7135872153845,2406.975731507692,{"y":2451.2378758,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1875.83,1915.0415168009615,1954.253033601923,1993.4645504028845,2032.676067203846,2071.8875840048076,2111.099100805769,2150.310617606731,2189.522134407692,2228.733651208654,2267.9451680096154,2307.1566848105767,2346.3682016115386,{"y":2385.5797184125,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1875.83,1899.889634326923,1923.949268653846,1948.008902980769,1972.0685373076924,1996.1281716346155,2020.1878059615385,2044.2474402884616,2068.307074615385,2092.366708942308,2116.426343269231,2140.485977596154,2164.545611923077,{"y":2188.60524625,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1375.131,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2042.556,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2042.556,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2285.072,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2094.543,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2045.902,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2045.902,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1676.767,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1676.767,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1875.83,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1875.83,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1875.83,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1875.83,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2,451Average Price Target$2,386Lowest Price Target$2,189
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on MX:EHC
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/17/26
Analyst Maintains Buy on Encompass Health as Model Tweaks Leave 2026 Revenue and EBITDA Outlook Intact
Barclays Analyst forecast on MX:EHC
Andrew Mok CFA
Barclays
Barclays
$2,451.24
Buy
―
Reiterated
07/09/26
Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (NASDAQ: BEAM), Encompass Health (NYSE: EHC) and Annexon Biosciences (NASDAQ: ANNX)
Truist Financial Analyst forecast on MX:EHC
David S Macdonald
Truist Financial
Truist Financial
$2,451.24
Buy
―
Reiterated
06/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (NYSE: EW), Encompass Health (NYSE: EHC) and Moderna (NASDAQ: MRNA)
TD Cowen Analyst forecast on MX:EHC
Ryan Langston
TD Cowen
TD Cowen
$2,188.61
Buy
―
Reiterated
06/16/26
Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)
KeyBanc Analyst forecast on MX:EHC
Matthew Gillmor CFA
KeyBanc
KeyBanc
―
Buy
―
Reiterated
06/12/26
Analysts' Top Healthcare Picks: Amgen (AMGN), Enliven Therapeutics (ELVN)
Bank of America Securities Analyst forecast on MX:EHC
Joanna Gajuk
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Savara (NASDAQ: SVRA), Encompass Health (NYSE: EHC) and SI-Bone (NASDAQ: SIBN)
Stephens Analyst forecast on MX:EHC
Unknown Analyst
Stephens
Not Ranked
Stephens
$2,451.24
Buy
―
Reiterated
05/04/26
Stephens Reaffirms Their Buy Rating on Encompass Health (EHC)
Mizuho Securities Analyst forecast on MX:EHC
Ann Hynes
Mizuho Securities
Mizuho Securities
$2,346.18
Buy
―
Reiterated
02/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (NASDAQ: PTCT), AptarGroup (NYSE: ATR) and Encompass Health (NYSE: EHC)
UBS Analyst forecast on MX:EHC
A.J. Rice
UBS
UBS
$2,451.24→$2,626.33
Buy
―
Reiterated
10/02/25
Encompass Health price target raised to $150 from $140 at UBSEncompass Health price target raised to $150 from $140 at UBS
Leerink Partners Analyst forecast on MX:EHC
Whit Mayo
Leerink Partners
Leerink Partners
$2,276.15→$2,346.18
Buy
―
Reiterated
08/06/25
Encompass Health: Strong Financial Performance and Growth Potential Drive Buy Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on MX:EHC
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/17/26
Analyst Maintains Buy on Encompass Health as Model Tweaks Leave 2026 Revenue and EBITDA Outlook Intact
Barclays Analyst forecast on MX:EHC
Andrew Mok CFA
Barclays
Barclays
$2,451.24
Buy
―
Reiterated
07/09/26
Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (NASDAQ: BEAM), Encompass Health (NYSE: EHC) and Annexon Biosciences (NASDAQ: ANNX)
Truist Financial Analyst forecast on MX:EHC
David S Macdonald
Truist Financial
Truist Financial
$2,451.24
Buy
―
Reiterated
06/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (NYSE: EW), Encompass Health (NYSE: EHC) and Moderna (NASDAQ: MRNA)
TD Cowen Analyst forecast on MX:EHC
Ryan Langston
TD Cowen
TD Cowen
$2,188.61
Buy
―
Reiterated
06/16/26
Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)
KeyBanc Analyst forecast on MX:EHC
Matthew Gillmor CFA
KeyBanc
KeyBanc
―
Buy
―
Reiterated
06/12/26
Analysts' Top Healthcare Picks: Amgen (AMGN), Enliven Therapeutics (ELVN)
Bank of America Securities Analyst forecast on MX:EHC
Joanna Gajuk
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Savara (NASDAQ: SVRA), Encompass Health (NYSE: EHC) and SI-Bone (NASDAQ: SIBN)
Stephens Analyst forecast on MX:EHC
Unknown Analyst
Stephens
Not Ranked
Stephens
$2,451.24
Buy
―
Reiterated
05/04/26
Stephens Reaffirms Their Buy Rating on Encompass Health (EHC)
Mizuho Securities Analyst forecast on MX:EHC
Ann Hynes
Mizuho Securities
Mizuho Securities
$2,346.18
Buy
―
Reiterated
02/09/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (NASDAQ: PTCT), AptarGroup (NYSE: ATR) and Encompass Health (NYSE: EHC)
UBS Analyst forecast on MX:EHC
A.J. Rice
UBS
UBS
$2,451.24→$2,626.33
Buy
―
Reiterated
10/02/25
Encompass Health price target raised to $150 from $140 at UBSEncompass Health price target raised to $150 from $140 at UBS
Leerink Partners Analyst forecast on MX:EHC
Whit Mayo
Leerink Partners
Leerink Partners
$2,276.15→$2,346.18
Buy
―
Reiterated
08/06/25
Encompass Health: Strong Financial Performance and Growth Potential Drive Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
ENOVEnovis
GKOSGlaukos
IFRXInflaRx
BKDBrookdale Senior Living
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Encompass Health

3 Months
Whit MayoLeerink Partners
Success Rate
12/17 ratings generated profit
71%
Average Return
+6.29%
Copying Whit Mayo's trades and holding each position for 3 Months would result in 70.59% of your transactions generating a profit, with an average return of +6.29% per trade.
1 Year
Ann HynesMizuho Securities
Success Rate
22/26 ratings generated profit
85%
Average Return
+19.80%
Copying Ann Hynes's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +19.80% per trade.
2 Years
Whit MayoLeerink Partners
Success Rate
15/17 ratings generated profit
88%
Average Return
+41.24%
Copying Whit Mayo's trades and holding each position for 2 Years would result in 88.24% of your transactions generating a profit, with an average return of +41.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EHC Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
2
1
1
0
Buy
6
12
15
16
12
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
14
16
17
12
In the current month, EHC has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EHC average Analyst price target in the past 3 months is 2,385.58.
Each month's total comprises the sum of three months' worth of ratings.

EHC Financial Forecast

EHC Earnings Forecast

Next quarter’s earnings estimate for EHC is $25.91 with a range of $24.86 to $26.44. The previous quarter’s EPS was $28.01. EHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year EHC has Performed in-line its overall industry.
Next quarter’s earnings estimate for EHC is $25.91 with a range of $24.86 to $26.44. The previous quarter’s EPS was $28.01. EHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year EHC has Performed in-line its overall industry.

EHC Sales Forecast

Next quarter’s sales forecast for EHC is $27.51B with a range of $27.34B to $27.80B. The previous quarter’s sales results were $27.78B. EHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year EHC has Performed in-line its overall industry.
Next quarter’s sales forecast for EHC is $27.51B with a range of $27.34B to $27.80B. The previous quarter’s sales results were $27.78B. EHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year EHC has Performed in-line its overall industry.

EHC Stock Forecast FAQ

What is MX:EHC’s average 12-month price target, according to analysts?
Based on analyst ratings, Encompass Health’s 12-month average price target is 2,385.58.
    What is MX:EHC’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:EHC, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Encompass Health a Buy, Sell or Hold?
        Encompass Health has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Encompass Health’s share price target?
          The average share price target for Encompass Health is 2,385.58. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $2,451.24 ,and the lowest forecast is $2,188.61. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Encompass Health?
            Encompass Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
              How can I buy shares of Encompass Health?
              To buy shares of MX:EHC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.